FDA Approved: DEFERASIROX — Supplemental Application (Xiromed, LLC)

View source ↗

Summary

FDA approved a supplemental application for Deferasirox submitted by Xiromed, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Transfusions

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)